Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack

NCT04304534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1601

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: BAY2433334
OTHER: BAY2433334 matching placebo

Sponsor

Bayer